Matinas Biopharma Holdings Net Income 2012-2019 | MTNB

Matinas Biopharma Holdings net income from 2012 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Matinas Biopharma Holdings Annual Net Income
(Millions of US $)
2019 $-18
2018 $-15
2017 $-33
2016 $-12
2015 $-9
2014 $-10
2013 $-4
2012 $-0
2011 $
Matinas Biopharma Holdings Quarterly Net Income
(Millions of US $)
2019-12-31 $-6
2019-09-30 $-5
2019-06-30 $-4
2019-03-31 $-4
2018-12-31 $-4
2018-09-30 $-3
2018-06-30 $-4
2018-03-31 $-4
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-21
2016-12-31 $-2
2016-09-30 $-6
2016-06-30 $-2
2016-03-31 $-2
2015-12-31 $-2
2015-09-30 $-2
2015-06-30 $-2
2015-03-31 $-3
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-2
2014-03-31 $-2
2013-12-31 $-2
2013-09-30 $-1
2013-06-30 $-0
2013-03-31 $-0
2012-12-31
2012-09-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.106B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.432B 34.96
Takeda Pharmaceutical (TAK) Japan $50.633B 8.87
Astellas Pharma (ALPMY) Japan $28.956B 14.46
Eisai (ESALY) Japan $20.668B 38.50
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $14.019B 17.43
Merck (MKGAF) Germany $12.608B 16.53
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.863B 246.23
Catalent (CTLT) United States $8.068B 33.19
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Ionis Pharmaceuticals (IONS) United States $7.309B 22.15
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.518B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.089B 7.42
Orion OYJ (ORINY) Finland $5.269B 23.61
IPSEN SA ADR (IPSEY) France $4.827B 0.00
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
United Therapeutics (UTHR) United States $4.239B 0.00
Evotec AG (EVTCY) Germany $3.769B 60.79
Hypermarcas (HYPMY) Brazil $3.762B 11.44
Nektar Therapeutics (NKTR) United States $3.274B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.203B 59.45
FibroGen (FGEN) United States $3.096B 0.00
PTC Therapeutics (PTCT) United States $2.765B 0.00
ChemoCentryx (CCXI) United States $2.672B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.451B 9.92
Xencor (XNCR) United States $1.736B 70.91
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.666B 0.00
Sage Therapeutics (SAGE) United States $1.558B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.557B 18.92
USANA Health Sciences (USNA) United States $1.529B 16.05
Theravance Biopharma (TBPH) Cayman Islands $1.481B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.403B 38.38
Corcept Therapeutics (CORT) United States $1.336B 14.95
Karyopharm Therapeutics (KPTI) United States $1.264B 0.00
Heron Therapeutics (HRTX) United States $1.263B 0.00
Zogenix (ZGNX) United States $1.110B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.039B 32.20
Esperion Therapeutics (ESPR) United States $0.990B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.928B 12.92
Akebia Therapeutics (AKBA) United States $0.903B 0.00
Endo (ENDP) Ireland $0.785B 1.45
CLINIGEN GP (CLIGF) United Kingdom $0.771B 0.00
Tilray (TLRY) Canada $0.726B 0.00
Molecular Templates (MTEM) United States $0.666B 0.00
Collegium Pharmaceutical (COLL) United States $0.627B 0.00
Aerie Pharmaceuticals (AERI) United States $0.622B 0.00
ImmunoGen (IMGN) United States $0.608B 0.00
Translate Bio (TBIO) United States $0.595B 0.00
Radius Health (RDUS) United States $0.582B 0.00
Portola Pharmaceuticals (PTLA) United States $0.543B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.430B 14.35
Siga Technologies (SIGA) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.414B 16.99
Indivior (INVVY) United States $0.397B 2.36
Calithera Biosciences (CALA) United States $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.379B 0.00
Ardelyx (ARDX) United States $0.376B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.345B 0.00
Trillium Therapeutics (TRIL) Canada $0.345B 0.00
Organogenesis Holdings (ORGO) United States $0.339B 0.00
Flexion Therapeutics (FLXN) United States $0.328B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.322B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.308B 0.00
DURECT (DRRX) United States $0.307B 0.00
Lannett Co Inc (LCI) United States $0.296B 4.76
Harpoon Therapeutics (HARP) United States $0.290B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.285B 0.00
Concert Pharmaceuticals (CNCE) United States $0.284B 0.00
Ocular Therapeutix (OCUL) United States $0.276B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.265B 0.00
TherapeuticsMD (TXMD) United States $0.263B 0.00
Rafael Holdings (RFL) United States $0.223B 0.00
PROFOUND MEDICL (PROF) Canada $0.194B 0.00
Recro Pharma (REPH) United States $0.189B 0.00
CASI Pharmaceuticals (CASI) United States $0.187B 0.00
OptiNose (OPTN) United States $0.172B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.172B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
KalVista Pharmaceuticals (KALV) United States $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.155B 2.80
Nature's Sunshine Products (NATR) United States $0.154B 19.29
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
VAXART, INC (VXRT) United States $0.119B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.105B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.088B 0.00
Aquestive Therapeutics (AQST) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
IMV INC (IMV) Canada $0.084B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.083B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
Biomerica (BMRA) United States $0.071B 0.00
Hemispherx BioPharma (AIM) United States $0.070B 0.00
Xeris Pharmaceuticals (XERS) United States $0.070B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 18.33
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
PharmAthene (ALT) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Aclaris Therapeutics (ACRS) United States $0.048B 0.00
Sundial Growers (SNDL) Canada $0.047B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 20.28
Neos Therapeutics (NEOS) United States $0.042B 0.00
MediWound (MDWD) Israel $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 133.29
Forward Pharma (FWP) Denmark $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Addex Therapeutics (ADXN) Switzerland $0.037B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.034B 0.00
IsoRay (ISR) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.032B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Cardiome Pharma (CORV) Canada $0.024B 0.00
ElectroCore (ECOR) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.022B 0.00
Lipocine (LPCN) United States $0.021B 0.00
Mannatechorporated (MTEX) United States $0.021B 6.58
Bio-Path Holdings (BPTH) United States $0.018B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Novan (NOVN) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Can-Fite Biopharma (CANF) Israel $0.013B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00